BSX
Boston Scientific Corp
43.30$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 36.9% | 37.9% | 36.3% | 35.1% | 34.1% | 35.9% | 43.8% | 37.2% | 39.2% | 38.0% | 38.7% | 31.0% | |
| 62.2% | 61.0% | 63.7% | 64.9% | 65.9% | 64.1% | 56.2% | 62.8% | 60.8% | 62.0% | 61.3% | 69.0% | |
| 11.1% | 11.7% | 11.0% | 11.0% | 11.3% | 10.9% | 11.5% | 10.1% | 10.4% | 9.9% | 9.6% | 10.2% | |
| 39.3% | 38.4% | 37.0% | 36.4% | 36.3% | 36.7% | 38.2% | 36.7% | 35.6% | 34.9% | 35.7% | 34.3% | |
| 50.7% | 50.5% | 49.0% | 48.0% | 48.3% | 48.1% | 50.2% | 46.6% | 46.4% | 46.7% | 45.6% | 49.2% | |
| 11.4% | 10.6% | 14.7% | 16.9% | 17.7% | 15.9% | 6.1% | 16.2% | 14.4% | 15.3% | 15.7% | 19.8% | |
| 2.9% | 3.2% | 2.8% | 2.5% | 2.7% | 4.8% | 4.7% | 2.9% | 3.7% | 1.9% | 2.3% | 1.7% | |
| -6.9% | -8.7% | 2.1% | 10.3% | 14.5% | 6.4% | -0.8% | 9.1% | 9.0% | 13.9% | 13.6% | 16.9% | |
| -2.4% | -5.5% | -2.0% | 9.2% | -2.5% | -37.4% | 0.0% | 0.3% | 3.5% | 2.8% | 2.6% | 2.5% | |
| -1.6% | -3.2% | 4.1% | 1.1% | 17.0% | 43.8% | -0.8% | 8.7% | 5.5% | 11.2% | 11.1% | 14.4% | |
| 5.9% | 4.8% | 14.6% | 22.2% | 26.3% | 20.6% | 15.2% | 21.2% | 21.6% | 24.2% | 23.5% | 25.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.